December issue reader poll
How to manage urolithiasis
Most relevant: 33%
Somewhat relevant: 55%
Least relevant: 12%
When to use PT for pelvic floor disorders
Most relevant: 33%
Somewhat relevant: 33%
Least relevant: 34%
Are you ready for office-based surgery?
Most relevant: 33%
Somewhat relevant: 44%
Least relevant: 23%
SMFM Consult: Isolated renal pelviectasis
Most relevant: 66%
Somewhat relevant: 33%
Least relevant: 1%
Editorial: Safe at home? Probably not
Most relevant: 44%
Somewhat relevant: 44%
Least relevant:12%
Clinical Insights
Most relevant: 77%
Somewhat relevant: 22%
Least relevant: 1%
Legally Speaking
Most relevant: 44%
Somewhat relevant: 55%
Least relevant: 1%
Comment: Make half of the editorial board non-academics since 90% of ob/gyn is not conducted in teaching hospitals and your articles have an academic bias to 24/7 resident MD services. Get input from 95% of regular docs who do not practice in 24/7 hospitals. The best example of this dichotomy is the VBAC issue where 95% of regular docs have rejected this approach but academics, the great majority of which do not personally deliver babies, but rather do most of their ob supervising residents. [They] have the arrogance, conceit, and gall to suggest that they know more about the safety of this procedure in small, community, and rural hospitals than the OBs who practice in them. So in the name of relevance, replace at least half of the editorial board with general OBs and require that any academic reviewing clinical articles have at least 1,500 personal deliveries and perform at least 50 personal deliveries a year-resident deliveries excluded. This will ensure that these academics actually have practical experience.
Article suggestion: Routine health screening for women
Article suggestion: Management of bladder during first and second stage labor with or without epidural anesthesia: Is there any study on this issue suggesting it hinders progress of labor if not emptied in a timely manner?
Article suggestion: Category 2 of FHR monitoring is still ambiguous and needs more refining. It would be nice to shed light on it.
SKYLIGHT trials confirm safety and efficacy of fezolinetant against sleep disturbances
September 13th 2024At the 2024 Annual Meeting of The Menopause Society, the positive safety and efficacy data of fezolinetant against sleep disturbances from the SKYLIGHT 1 and 2 trials was presented.
Read More
Study shows hormone therapy offers lasting benefits for women over 65
September 12th 2024A new study presented at the 2024 Annual Meeting of The Menopause Society shows hormone therapy remains beneficial for women over 65, helping manage menopause symptoms like hot flashes and improving quality of life.
Read More